Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction

Area of Science:

• Ophthalmology
• Neuroscience
• Immunology

Background:

• The renin-angiotensin system (RAS) is recognized for blood pressure regulation and its role as a proinflammatory mediator.
• Intrinsic RAS production in tissues allows dynamic responses to local and systemic cues.
• Hyperactivation of RAS contributes to neural dysfunction and pathological glial responses.

Purpose of the Study:

• To explore the role of the renin-angiotensin system (RAS) in ocular and neurodegenerative diseases.
• To investigate the potential of RAS inhibition as a therapeutic strategy for inflammatory and neurodegenerative conditions.

Main Methods:

• Review of existing literature on RAS, inflammation, and ocular/neurodegenerative diseases.
• Analysis of evidence linking RAS hyperactivation to neuronal protein degradation and glial activation.
• Examination of studies on RAS inhibition in models of uveitis, diabetic retinopathy, age-related macular degeneration, and glaucoma.

Main Results:

• RAS hyperactivation accelerates neuronal protein degradation and activates pathological glial responses, contributing to neural dysfunction.
• Chronic inflammation and oxidative stress, exacerbated by RAS, are risk factors for diabetic retinopathy, age-related macular degeneration, and glaucoma.
• Evidence suggests RAS inhibition can prevent the progression of uveitis, diabetic retinopathy, age-related macular degeneration, and glaucoma.

Conclusions:

• RAS plays a critical role in modulating inflammatory responses, with hyperactivation leading to detrimental effects in ocular and neural tissues.
• RAS inhibition presents a promising therapeutic avenue for managing inflammatory responses and potentially treating or preventing vision-threatening diseases and neurodegeneration.